{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:07Z","timestamp":1791928927230,"version":"4.3.4"},"reference-count":29,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"11","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2025,8,20]]},"DOI":"10.1167\/iovs.66.11.48","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T14:30:43Z","timestamp":1755700243000},"page":"48","source":"Crossref","is-referenced-by-count":3,"title":["Dynamics of the EZ\/RPE Loss Ratio on OCT Over Time During Geographic Atrophy Progression and Treatment With Pegcetacoplan"],"prefix":"10.1167","volume":"66","author":[{"given":"Julia","family":"Mai","sequence":"first","affiliation":[{"name":"OPTIMA - Laboratory for Ophthalmic Image Analysis, Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor S.","family":"Reiter","sequence":"additional","affiliation":[{"name":"OPTIMA - Laboratory for Ophthalmic Image Analysis, Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Riedl","sequence":"additional","affiliation":[{"name":"OPTIMA - Laboratory for Ophthalmic Image Analysis, Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf-Dieter","family":"Vogl","sequence":"additional","affiliation":[{"name":"RetInSight, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Sadeghipour","sequence":"additional","affiliation":[{"name":"RetInSight, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"McKeown","sequence":"additional","affiliation":[{"name":"Apellis Pharmaceuticals, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Foos","sequence":"additional","affiliation":[{"name":"Apellis Pharmaceuticals, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrvoje","family":"Bogunovic","sequence":"additional","affiliation":[{"name":"Institute of Artificial Intelligence \/ Center for Medical Data Science, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Schmidt-Erfurth","sequence":"additional","affiliation":[{"name":"OPTIMA - Laboratory for Ophthalmic Image Analysis, Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"10411","key":"bib1","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial","volume":"402","author":"Khanani","year":"2023","journal-title":"Lancet"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"101305","DOI":"10.1016\/j.preteyeres.2024.101305","article-title":"AI in the clinical management of GA: a novel therapeutic universe requires novel tools","volume":"103","author":"Reiter","year":"2024","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"bib4","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.ophtha.2018.05.028","article-title":"Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16","volume":"125","author":"Keenan","year":"2018","journal-title":"Ophthalmology"},{"issue":"2","key":"bib5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ophtha.2015.09.036","article-title":"Natural history of geographic atrophy progression secondary to age-related macular degeneration (geographic atrophy progression study)","volume":"123","author":"Schmitz-Valckenberg","year":"2016","journal-title":"Ophthalmology"},{"issue":"3","key":"bib6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","article-title":"The progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"issue":"5","key":"bib7","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.ophtha.2016.01.034","article-title":"Anatomic clinical trial endpoints for nonexudative age-related macular degeneration","volume":"123","author":"Schaal","year":"2016","journal-title":"Ophthalmology"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ajo.2017.03.031","article-title":"Geographic atrophy and foveal-sparing changes related to visual acuity in patients with dry age-related macular degeneration over time","volume":"179","author":"Sayegh","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"bib9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.oret.2022.11.012","article-title":"The underreporting of age-related geographic atrophy of the macula","volume":"7","author":"Sunness","year":"2023","journal-title":"Ophthalmology Retina"},{"issue":"10","key":"bib11","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1097\/IAE.0000000000001283","article-title":"Clinical endpoints for the study of geographic atrophy secondary to age-related macular degeneration","volume":"36","author":"Sadda","year":"2016","journal-title":"Retina"},{"issue":"4","key":"bib12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000330420","article-title":"Imaging geographic atrophy in age-related macular degeneration","volume":"226","author":"G\u00f6bel","year":"2011","journal-title":"Ophthalmologica"},{"issue":"6","key":"bib13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1167\/iovs.61.6.11","article-title":"Subretinal drusenoid deposits and photoreceptor loss detecting global and local progression of geographic atrophy by SD-OCT imaging","volume":"61","author":"Reiter","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"bib14","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1001\/jamaophthalmol.2020.2914","article-title":"Progression of photoreceptor degeneration in geographic atrophy secondary to age-related macular degeneration","volume":"138","author":"Pfau","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"bib15","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.oret.2022.05.030","article-title":"The effect of pegcetacoplan treatment on photoreceptor maintenance in geographic atrophy monitored by artificial intelligence-based OCT analysis","volume":"6","author":"Riedl","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"bib16","doi-asserted-by":"publisher","first-page":"17870","DOI":"10.1038\/s41598-022-22404-9","article-title":"Association of complement C3 inhibitor pegcetacoplan with reduced photoreceptor degeneration beyond areas of geographic atrophy","volume":"12","author":"Pfau","year":"2022","journal-title":"Sci Rep"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ophtha.2024.08.017","article-title":"Disease activity and therapeutic response to pegcetacoplan for geographic atrophy identified by deep learning-based analysis of OCT","volume":"132","author":"Schmidt-Erfurth","year":"2025","journal-title":"Ophthalmology"},{"issue":"8","key":"bib18","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1136\/bjophthalmol-2014-305195","article-title":"A systematic correlation of morphology and function using spectral domain optical coherence tomography and microperimetry in patients with geographic atrophy","volume":"98","author":"Sayegh","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ajo.2016.06.006","article-title":"Photoreceptor damage and reduction of retinal sensitivity surrounding geographic atrophy in age-related macular degeneration","volume":"168","author":"Takahashi","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ajo.2024.11.005","article-title":"Repeatability of microperimetry in areas of RPE and photoreceptor loss in geographic atrophy supported by AI-based OCT biomarker quantification","volume":"271","author":"Coulibaly","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ajo.2022.06.023","article-title":"Comparison of fundus autofluorescence versus optical coherence tomography-based evaluation of the therapeutic response to pegcetacoplan in geographic atrophy","volume":"244","author":"Mai","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"bib24","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.1038\/s41598-020-62329-9","article-title":"Automated quantification of photoreceptor alteration in macular disease using optical coherence tomography and deep learning","volume":"10","author":"Orlando","year":"2020","journal-title":"Sci Rep"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/bjo-2023-323708","article-title":"Deep-learning automated quantification of longitudinal OCT scans demonstrates reduced RPE loss rate, preservation of intact macular area and predictive value of isolated photoreceptor degeneration in geographic atrophy patients receiving C3 inhibition treatment","volume":"108","author":"Fu","year":"2024","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"bib26","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1097\/IAE.0b013e31828d6052","article-title":"Spectral domain optical coherence tomography-determined morphologic predictors of age-related macular degeneration-associated geographic atrophy progression","volume":"33","author":"Moussa","year":"2013","journal-title":"Retina"},{"issue":"8","key":"bib27","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1167\/iovs.09-4533","article-title":"Tracking progression with spectral-domain optical coherence tomography in geographic atrophy caused by age-related macular degeneration","volume":"51","author":"Fleckenstein","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"bib28","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/j.ophtha.2009.04.015","article-title":"Spectral domain optical coherence tomography imaging of geographic atrophy margins","volume":"116","author":"Bearelly","year":"2009","journal-title":"Ophthalmology"},{"issue":"9","key":"bib29","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.oret.2023.05.004","article-title":"Progression dynamics of early versus later stage atrophic lesions in nonneovascular age-related macular degeneration using quantitative OCT biomarker segmentation","volume":"7","author":"Coulibaly","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"bib10","article-title":"Visual function benefit of pegcetacoplan on a prespecified microperimetry endpoint after 36 months of continuous treatment from GALE","volume-title":"Paper presented at the American Society of Retina Specialists (ASRS) 42nd Annual Meeting","author":"Garg","year":"2024"},{"key":"bib21","article-title":"StealthBio therapeutics announces positive end-of-phase 2 meeting with FDA on the development of elamipretide in patients with dry age-related macular degeneration","author":"Stealth"},{"key":"bib23","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-87193-2_41","article-title":"Projective skip-connections for segmentation along a subset of dimensions in retinal OCT","volume-title":"Paper presented at: Medical Image Computing and Computer Assisted Intervention \u2013 MICCAI 2021","author":"Lachinov","year":"2021"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2810699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:06Z","timestamp":1791927126000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2810699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.11.48","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,20]]}}}